| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.91B | 1.81B | 1.41B | 986.30M | 563.80M | 421.00M |
| Gross Profit | 680.20M | 1.31B | 1.10B | 638.20M | 369.10M | 260.50M |
| EBITDA | 551.00M | 598.60M | 520.00M | 179.70M | 71.20M | 70.40M |
| Net Income | 386.60M | 416.70M | 354.60M | 114.00M | 32.90M | 30.90M |
Balance Sheet | ||||||
| Total Assets | 22.11B | 19.25B | 15.14B | 11.90B | 7.56B | 4.30B |
| Cash, Cash Equivalents and Short-Term Investments | 1.58B | 12.83B | 9.22B | 7.65B | 2.32B | 1.62B |
| Total Debt | 301.30M | 185.60M | 224.20M | 264.40M | 95.70M | 98.70M |
| Total Liabilities | 20.68B | 17.86B | 14.16B | 11.33B | 7.16B | 4.02B |
| Stockholders Equity | 1.43B | 1.39B | 979.90M | 576.90M | 409.20M | 285.30M |
Cash Flow | ||||||
| Free Cash Flow | 598.40M | 4.46B | 3.24B | 3.91B | 3.13B | 2.05B |
| Operating Cash Flow | 632.90M | 4.49B | 3.25B | 3.92B | 3.14B | 2.07B |
| Investing Cash Flow | -714.20M | -598.40M | -142.60M | -2.59B | -490.40M | -671.80M |
| Financing Cash Flow | 4.67B | -181.30M | -125.60M | 153.90M | -1.30M | 24.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £11.80B | 14.20 | 27.43% | ― | 8.87% | -10.29% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | £14.37M | -4.40 | -67.57% | ― | -12.11% | -106.04% | |
39 Underperform | £5.81M | -17.66 | -29.54% | ― | -44.27% | -350.00% |